Eroom's law

English

Moore's law spelled backwards, coined in a 2012 paper.^[1]

Eroom's law

(pharmacology) The observation that drug discovery is becoming slower and more expensive over time, despite improvements in technology.
- 2014, Jeremy A. Greene, Generic: The Unbranding of Modern Medicine, JHU Press, →ISBN, page 271:
  Eroom's Law, in turn, observes that in the pharmaceutical sector the decline in innovation is itself constant: the yield of FDA-approved drugs per billion dollars spent has halved every nine years between 1950 and 2010.
- 2018, Mark Stevenson, We Do Things Differently: The Outsiders Rebooting Our World‎^[1], Abrams, →ISBN:
  With a touch of wry humour, the authors dubbed this phenomenon Eroom's law, the reverse spelling of Moore's Law – the famous law of computing that expresses the doubling of processing power per dollar every two years […]

^ Jack W. Scannell, Alex Blanckley, Helen Boldon, Brian Warrington (2012) “Diagnosing the decline in pharmaceutical R&D efficiency”, in Nature Reviews. Drug Discovery, volume 11, number 3, →DOI, →PMID, pages 191–200